4d
Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...
Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.
Irish Independent on MSN4d
‘We’re very much an Irish story all the way’ – Neuromod raises €10m to expand its tinnitus treatmentIrish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...
Irish Examiner on MSN5d
Irish med device expands its tinnitus treatment for US military vetsNeuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...
Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 ...
Medical Device Network on MSN4d
Neuromod secures €10m to expand tinnitus treatment device’s availabilityNeuromod Devices has secured €10m ($10.8m) in equity financing to broaden the reach of Lenire, its treatment device.
In June 2024, Neuromod was awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government, making Lenire a treatment option for the 2.9 million US Veterans ...
Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.
Neuromod has been making Lenire available through audiology and ENT practices throughout the USA and Europe. Proceeds from the financing will be used to meet demand for Lenire through sustainable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results